138 related articles for article (PubMed ID: 29201711)
1. Propylthiouracil-related Toxic Hepatitis: Impact of Silent Cases.
Eser M; Basyigit S; Eser M; Nazligul Y
Euroasian J Hepatogastroenterol; 2015; 5(2):134-135. PubMed ID: 29201711
[TBL] [Abstract][Full Text] [Related]
2. A Case of Propylthiouracil-Induced Hepatitis during Pregnancy.
Taylor P; Bhatt S; Gouni R; Quinlan J; Robinson T
Eur Thyroid J; 2012 Apr; 1(1):41-4. PubMed ID: 24782996
[TBL] [Abstract][Full Text] [Related]
3. Propylthiouracil hepatitis: report of a case and extensive review of the literature.
Memi E; Karras S; Tzotzas T; Krassas GE
J Pediatr Endocrinol Metab; 2012; 25(3-4):331-43. PubMed ID: 22768665
[TBL] [Abstract][Full Text] [Related]
4. Gone (from the Physicians' desk reference) but not forgotten: propylthiouracil-associated hepatic failure: a call for liver test monitoring.
Primeggia J; Lewis JH
J Natl Med Assoc; 2010 Jun; 102(6):531-4. PubMed ID: 20575220
[TBL] [Abstract][Full Text] [Related]
5. A case of thyroid storm complicated by acute hepatitis due to propylthiouracil treatment.
Tufton N; Hashim N; Sze C; Waterhouse M
Endocrinol Diabetes Metab Case Rep; 2015; 2015():150052. PubMed ID: 26279851
[TBL] [Abstract][Full Text] [Related]
6. A case of autoimmune hepatitis with Graves' disease treated by propylthiouracil.
Sato I; Tsunekawa T; Shinohara Y; Nishio Y; Shimizu Y; Suzuki Y; Yoshioka S
Nagoya J Med Sci; 2011 Aug; 73(3-4):205-9. PubMed ID: 21928702
[TBL] [Abstract][Full Text] [Related]
7. SERIAL CHANGES OF LIVER FUNCTION TESTS BEFORE AND DURING METHIMAZOLE TREATMENT IN THYROTOXIC PATIENTS.
Niculescu DA; Dusceac R; Galoiu SA; Capatina CA; Poiana C
Endocr Pract; 2016 Aug; 22(8):974-9. PubMed ID: 27042749
[TBL] [Abstract][Full Text] [Related]
8. [Asymptomatic hepatitis induced by propylthiouracil].
De Castro JJ; Nobre EL; Garcia e Costa J; Galvão-Teles A
Acta Med Port; 2001; 14(5-6):523-7. PubMed ID: 11878166
[TBL] [Abstract][Full Text] [Related]
9. Relapsing hairy cell leukemia presenting as fulminant hepatitis.
Evans MA; Gastineau DA; Ludwig J
Am J Med; 1992 Feb; 92(2):209-12. PubMed ID: 1543207
[TBL] [Abstract][Full Text] [Related]
10. [Propylthiouracil-induced overt hepatic injury in patients with hyperthyroidism].
Lian XL; Bai Y; Dai WX; Guo ZS; Li W; Lu L
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):172-7. PubMed ID: 15171556
[TBL] [Abstract][Full Text] [Related]
11. [Fluctuations in the titers of anti-thyroid hormone and anti-thyroglobulin antibodies in 4 cases of Graves' disease during long-term treatment period].
Komaki T; Sakata S; Nakamura S; Matsuda M; Kojima N; Takuno H; Miura K
Nihon Naibunpi Gakkai Zasshi; 1989 Jul; 65(7):627-39. PubMed ID: 2583311
[TBL] [Abstract][Full Text] [Related]
12. [The clinical characteristics of symptomatic propylthiouracil-induced hepatic injury in patients with hyperthyroidism].
Lian XL; Bai Y; Dai WX; Jin ZM; Zeng ZP; Guo ZS
Zhonghua Nei Ke Za Zhi; 2004 Jun; 43(6):442-6. PubMed ID: 15312442
[TBL] [Abstract][Full Text] [Related]
13. Fulminant hepatitis and elevated levels of sIL-2R in thyroid storm.
Tanaka Y; Uchida T; Yamaguchi H; Kudo Y; Yonekawa T; Nakazato M
Endocrinol Diabetes Metab Case Rep; 2019 Sep; 2019():. PubMed ID: 31600730
[TBL] [Abstract][Full Text] [Related]
14. Methylprednisolone-induced toxic hepatitis.
Topal F; Ozaslan E; Akbulut S; Küçükazman M; Yüksel O; Altiparmak E
Ann Pharmacother; 2006 Oct; 40(10):1868-71. PubMed ID: 16926305
[TBL] [Abstract][Full Text] [Related]
15. Sequential liver and bone biochemical changes in hyperthyroidism: prospective controlled follow-up study.
Huang MJ; Li KL; Wei JS; Wu SS; Fan KD; Liaw YF
Am J Gastroenterol; 1994 Jul; 89(7):1071-6. PubMed ID: 7912472
[TBL] [Abstract][Full Text] [Related]
16. Neonatal hepatitis and lymphocyte sensitization by placental transfer of propylthiouracil.
Hayashida CY; Duarte AJ; Sato AE; Yamashiro-Kanashiro EH
J Endocrinol Invest; 1990 Dec; 13(11):937-41. PubMed ID: 2090674
[TBL] [Abstract][Full Text] [Related]
17. Hepatobiliary complications of oral contraceptives.
Lindberg MC
J Gen Intern Med; 1992; 7(2):199-209. PubMed ID: 1336797
[TBL] [Abstract][Full Text] [Related]
18. Antineutrophilic cytoplasmic antibody-positive systemic vasculitis associated with propylthiouracil therapy: report of 2 children with Graves' disease.
Poomthavorn P; Mahachoklertwattana P; Tapaneya-Olarn W; Chuansumrit A; Chunharas A
J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1295-301. PubMed ID: 12549809
[TBL] [Abstract][Full Text] [Related]
19. Propylthiouracil-induced severe hepatitis: a case report and review of the literature.
Ichiki Y; Akahoshi M; Yamashita N; Morita C; Maruyama T; Horiuchi T; Hayashida K; Ishibashi H; Niho Y
J Gastroenterol; 1998 Oct; 33(5):747-50. PubMed ID: 9773944
[TBL] [Abstract][Full Text] [Related]
20. The effect of propylthiouracil on subsequent radioactive iodine therapy in Graves' disease.
Hancock LD; Tuttle RM; LeMar H; Bauman J; Patience T
Clin Endocrinol (Oxf); 1997 Oct; 47(4):425-30. PubMed ID: 9404440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
